DA
AMRX icon

Denali Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Denali Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-337
Closed -$1.04K – 471
2023
Q2 		$1.04K Sell
337
-9
-3% -$19 ﹤0.01% 442
2023
Q1 		$481 Sell
346
-139
-29% -$277 ﹤0.01% 424
2022
Q4 		$965 Buy
+485
New +$1.09K ﹤0.01% 395

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Denali Advisors's AMRX Position: Q3 2023 in Review

Denali Advisors sold out of Amneal Pharmaceuticals (AMRX) in Q3 2023, closing a stake of 337 shares — an estimated $1.04K sold.

Denali Advisors first reported a position in AMRX in Q4 2022 and held it in 3 quarters. The position peaked at $1.04K in Q2 2023. 144 funds tracked by Wall St. Rank hold AMRX as of Q3 2023.

  • Denali Advisors reported no remaining Amneal Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Denali Advisors sold 337 Amneal Pharmaceuticals shares in Q3 2023, an estimated $1.04K.
  • Denali Advisors first reported a position in Amneal Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • Denali Advisors's Amneal Pharmaceuticals position peaked at $1.04K in Q2 2023.
  • 144 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2023.

Based on Denali Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.